Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is evaluating the efficacy and safety of SC antifrolumab in adult patients with moderate -to-severe SLE despite receiving standard therapy
Epistemonikos ID: 9cce215a97ec0d043beef48c00748dc98717aaae
First added on: May 08, 2024